Results 81 to 90 of about 12,338 (187)

Neurofilament light chain reflects motor impairment in myotonic dystrophy type 1. [PDF]

Front Neurol
Shin CH, Seo I, Kim YR, Park JM, Park JS.   +4 more
europepmc   +1 more source

Bottlebrush polymer conjugates for enhanced antisense oligonucleotide therapy in myotonic dystrophy type 1. [PDF]

Nucleic Acids Res
Li Y, Oetheimer C, Wang Y, Heo GS, Wu J, Chang R, Zhang W, Schneider E, Chen J, Fang Y, Wei Y, Nian K, Zhang H, Sherman L, Liu Y, Zhang K.   +15 more
europepmc   +1 more source

Fading Muscle and a Flaccid Bladder: Atonic Bladder in a Case of Myotonic Dystrophy-A Case Report. [PDF]

Ann Neurosci
Ravichandran PY, R K, Madhavan K.
europepmc   +1 more source

Test-Retest Reliability of Remote Assessments in Patients With Myotonic Dystrophy Type 1. [PDF]

Neurology
Tufano L, Richardson E, Dekdebrun JM, Stanton E, Warnasooriya C, Docteur M, Eichinger K, Hamel JI.   +7 more
europepmc   +1 more source

Intraocular pressure and corneal biomechanics in patients affected by myotonic dystrophy type 1. [PDF]

Graefes Arch Clin Exp Ophthalmol
Lanza M, Boccia R, Scutifero M, Serra L, Cangiano T, Picillo E, Fattore I, Nigro V, Simonelli F.   +8 more
europepmc   +1 more source

Oleic Acid Levels in HSA^LR Mouse Model of Myotonic Dystrophy Type 1. [PDF]

Int J Mol Sci
Peris-Moreno D, Sabater-Arcis M, Moreno N, Orduña L, López-Castel A, Bargiela A, Artero R.   +6 more
europepmc   +1 more source

Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in Childhood. [PDF]

Neurol Genet
Kiefer M, Hartman JM, Berggren KN, Butler A, Jones AS, McIntyre M, Hung M, Carrell S, Hale MA, Campbell C, Sansone VA, Johnson NE.   +11 more
europepmc   +1 more source

Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study. [PDF]

BMC Neurol
Fortin J, Gaudet I, Côté I, Gagnon C, Gallais B.   +4 more
europepmc   +1 more source

Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides. [PDF]

Dis Model Mech
Marzullo M, De Simone A, Terribili M, Di Salvio M, Mengistu DY, Somma MP, D'Amico R, Canettieri G, Cestra G, Ciapponi L.   +9 more
europepmc   +1 more source

Commitment to Myogenic Differentiation Significantly Aggravates the RNA Phenotype in Myotonic Dystrophy Type 1. [PDF]

Neuropathol Appl Neurobiol
Ripken L, van den Broek WJAA, van Cruchten RTP, Smits JGA, Riepe TV, 't Hoen PAC, Wansink DG.   +6 more
europepmc   +1 more source